(Q68311242)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behçeťs disease (English)

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

27 October 2022

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

27 October 2022

author

Elizabeth F. Sherertz

5

object named as

E F Sherertz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

J. L. Jorizzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678395

27 October 2022

W. L. White

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678395

27 October 2022

C. M. Wise

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678395

27 October 2022

M. D. Zanolli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678395

27 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:019096229170156V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

https://api.elsevier.com/content/article/PII:019096229170156V?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Journal of the American Academy of Dermatology

27 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

6 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

973-978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate for the Treatment of Mucha-Habermann Disease

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Treatment of dermatomyositis with methotrexate

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Pemphigus and pemphigoid. A review of the advances made since 1964.

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate: anti-inflammatory or antiproliferative?

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

The effect of methotrexate and hydroxyurea on neutrophil chemotaxis

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Flow cytometric quantification of T6-positive cells in psoriatic epidermis after PUVA and methotrexate therapy

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate therapy in cutaneous sarcoidosis

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate in lymphomatoid papulosis

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate in the treatment of arthritis and connective tissue diseases

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Cutaneous periarteritis nodosa

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

The treatment of disseminated vasculitis with methotrexate

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Neutrophilic vascular reactions

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

27 October 2022

Behçet's disease

27

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

Methotrexate in psoriasis: revised guidelines

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70156-V

27 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1678395%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference